Status:
COMPLETED
Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis
Lead Sponsor:
Isfahan University of Medical Sciences
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
The purpose of this study is to compare the effect of combinative induction therapy with mitoxantrone and plasmapheresis versus induction therapy with mitoxantrone alone in cases of aggressive multipl...
Eligibility Criteria
Inclusion
- Aggressive multiple sclerosis in attack phase
- EDSS: 1-5
- No contraindication for mitoxantrone prescription
- No past history of mitoxantrone injection
- No history of corticosteroid and immunosuppressive therapy in last 3 months
Exclusion
- Patient's incompliance
- Severe drug induced side effects
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01214317
Start Date
January 1 2010
End Date
February 1 2012
Last Update
September 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alahra hospital
Isfahan, Iran